Benitec Biopharma Inc (BNTC)
9.49
+0.02
(+0.21%)
USD |
NASDAQ |
May 17, 16:00
8.91
-0.58
(-6.11%)
After-Hours: 20:00
Benitec Biopharma Cash from Investing (TTM): -0.18M for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.18M |
| December 31, 2023 | -0.001M |
| September 30, 2023 | -0.001M |
| June 30, 2023 | -0.001M |
| March 31, 2023 | -0.013M |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | 0.126M |
| September 30, 2021 | -0.048M |
| June 30, 2021 | -0.221M |
| March 31, 2021 | -0.375M |
| December 31, 2020 | -0.36M |
| Date | Value |
|---|---|
| September 30, 2020 | -0.268M |
| June 30, 2020 | -0.094M |
| March 31, 2020 | -0.0501M |
| December 31, 2019 | -0.0462M |
| September 30, 2019 | -0.0756M |
| June 30, 2018 | -0.108M |
| March 31, 2018 | -0.1575M |
| December 31, 2017 | -0.1818M |
| September 30, 2017 | -0.2207M |
| June 30, 2017 | -0.2321M |
| March 31, 2017 | -0.3111M |
| December 31, 2016 | 1.060M |
| September 30, 2016 | -0.2582M |
| June 30, 2016 | -0.2554M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-0.375M
Minimum
Mar 2021
0.126M
Maximum
Dec 2021
-0.1072M
Average
-0.0501M
Median
Mar 2020
Cash from Investing (TTM) Benchmarks
| Galectin Therapeutics Inc | -- |
| TG Therapeutics Inc | -53.74M |
| BioVie Inc | 0.2239M |
| Jaguar Health Inc | -- |
| Entero Therapeutics Inc | -- |